05:56 PM EST, 02/14/2025 (MT Newswires) -- Neil F. McFarlane, Director, President and CEO, on February 13, 2025, sold 91,817 shares in Zevra Therapeutics ( ZVRA ) for $727,390. Following the Form 4 filing with the SEC, McFarlane has control over a total of 191,516 common shares of the company, with 191,516 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1434647/000143774925004067/xslF345X05/rdgdoc.xml